Proteins of purified Epstein-Barr virus
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Mature Epstein-Barr virus (EBV) was purified from the culture medium of infected lymphocytes made functionally conditional for Zta activation of lytic replication by an in-frame fusion with a mutant estrogen receptor. Proteins in purified virus preparations were separated by gradient gel electrophoresis and trypsin-digested; peptides were then analyzed by tandem hydrophobic chromatography, tandem MS sequencing, and MS scans. Potential peptides were matched with EBV and human gene ORFs. Mature EBV was mostly composed of homologues of proteins previously found in a herpes virion. However, EBV homologues to herpes simplex virus capsid-associated or tegument components UL7 (BBRF2), UL14 (BGLF3), and EBV BFRF1 were not significantly detected. Instead, probable tegument components included the EBV and γ-herpesvirus-encoded BLRF2, BRRF2, BDLF2 and BKRF4 proteins. Actin was also a major tegument protein, and cofilin, tubulin, heat shock protein 90, and heat shock protein 70 were substantial components. EBV envelope glycoprotein gp350 was highly abundant, followed by glycoprotein gH, intact and furin-cleaved gB, gM, gp42, gL, gp78, gp150, and gN. BILF1 (gp64) and proteins associated with latent EBV infection were not detected in virions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For compositional analysis, most studies have focused on viruses with high proteomic complexity, including those in the families Herpesviridae (4–9) and Poxviridae (10–12).”
From The Impact of Mass Spectrometry–Based Proteomics on Fundamental Discoveries in Virology (2014) · cites this paper as [4]
Citations
Cites
DNA sequence and expression of the B95-8 Epstein—Barr virus genome
Baer, R., Bankier, A. T., Biggin, M. D., Deininger, P. L., Farrell, P. J., Gibson, T. J., Hatfull, G., Hudson, G. S., Satchwell, S. C., Séguin, C., et al. (1984) · Nature · doi:10.1038/310207a0 · Cited by 2,053
Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)
Russo, J. J., Bohenzky, R. A., Chien, M.-C., Chen, J., Yan, M., Maddalena, D., Parry, J. P., Peruzzi, D., Edelman, I. S., Chang, Y., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14862 · Cited by 1,467
Three-Dimensional Structure of Herpes Simplex Virus from Cryo-Electron Tomography
Grünewald, K., Desai, P., Winkler, D. C., Heymann, J. B., Belnap, D. M., Baumeister, W., & Steven, A. C. (2003) · Science · doi:10.1126/science.1090284 · Cited by 586
Evolution of the herpesviruses
Davison, A. J. (2002) · Veterinary Microbiology · doi:10.1016/s0378-1135(01)00492-8 · Cited by 336
Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes
Li, Q., Spriggs, M. K., Kovats, S., Turk, S. M., Comeau, M. R., Nepom, B., & Hutt-Fletcher, L. M. (1997) · Journal of Virology · doi:10.1128/jvi.71.6.4657-4662.1997 · Cited by 319
The UL6 Gene Product Forms the Portal for Entry of DNA into the Herpes Simplex Virus Capsid
Newcomb, W. W., Juhas, R. M., Thomsen, D. R., Homa, F. L., Burch, A. D., Weller, S. K., & Brown, J. C. (2001) · Journal of Virology · doi:10.1128/jvi.75.22.10923-10932.2001 · Cited by 309
Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells
Tugizov, S. M., Berline, J. W., & Palefsky, J. M. (2003) · Nature Medicine · doi:10.1038/nm830 · Cited by 286
Proteins associated with purified human cytomegalovirus particles
Baldick, C. J., & Shenk, T. (1996) · Journal of Virology · doi:10.1128/jvi.70.9.6097-6105.1996 · Cited by 176
Spear, G. T., Lurain, N. S., Parker, C. J., Ghassemi, M., Payne, G. H., & Saifuddin, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.9.4376 · Cited by 169
Grogan, E. A., Jenson, H. B., Countryman, J. K., Heston, L., Gradoville, L., & Miller, G. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.5.1332 · Cited by 137
Research works printed but not linked: 2
- Hutt-Fletcher, L. M. & Lake, C. M. (2001) Curr. Top. Microbiol. Immunol. 258, 51-64.11443867
- Iwase, H. & Hotta, K. (1993) Methods Mol. Biol. 14, 151-159.8348231
Cited by
Items 301–400 of 450
Assessing the Efficacy of VLP-Based Vaccine against Epstein-Barr Virus Using a Rabbit Model
Reguraman, N., Hassani, A., Philip, P. S., Pich, D., Hammerschmidt, W., & Khan, G. (2023) · Vaccines · doi:10.3390/vaccines11030540 · Cited by 10
“Independent analysis using mass spectrometry indicated that the VLPs contained approximately 50 viral proteins in different concentrations mimicking the composition of B95-8 virus stocks [30].”
MethodLin, S., Zhou, H., Chen, G., Xue, J., Liu, Q., Li, J., Yang, Y., Zhao, Y., Bao, H., Huang, Y., et al. (2024) · BMC Cancer · doi:10.1186/s12885-024-12564-4 · Cited by 10
“The BKRF2 gene is a true-late lytic gene during EBV reactivation which encodes glycoprotein L [16].”
Albright, E. R., Walter, R. M., Saffert, R. T., & Kalejta, R. F. (2023) · Journal of Virology · doi:10.1128/jvi.00029-23 · Cited by 11
“(C to E) THP1 monocytes treated without (2) or with (1) 1 mM VPA mock infected (2) or infected with wild-type AD169 (AD, 1) at an MOI of 1 for 18 h in the absence (2) or presence (1) of BMS.”
MethodSkike, N. D. V., Minkah, N. K., Hogan, C. H., Wu, G., Benziger, P. T., Oldenburg, D. G., Kara, M., Kim, D., White, D. W., Tibbetts, S. A., et al. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1006843 · Cited by 10
Jefferson, V. A., Barber, K. A., El-mayet, F. S., Jones, C., Nanduri, B., & Meyer, F. (2018) · Viruses · doi:10.3390/v10090499 · Cited by 9
Epstein-Barr virus: vaccine development
Solomay, T. V., Семененко, Т. А., Nn, F., Костинов, М. П., & Ilina, N. I. (2020) · Immunologiya · doi:10.33029/0206-4952-2020-41-3-381-390 · Cited by 10
Wang, J., Chuang, Y.-C., Chen, K., Lu, C.-C., Doong, S.-L., Cheng, H.-H., Chen, Y.-L., Liu, T.-T., Chang, Y., Han, C.-H., et al. (2010) · Journal of General Virology · doi:10.1099/vir.0.019729-0 · Cited by 10
The Marek's disease virus (MDV) protein encoded by the UL17 ortholog is essential for virus growth
Chbab, N., Chabanne-Vautherot, D., Francineau, A., Osterrieder, N., Denesvre, C., & Vautherot, J.-F. (2009) · Veterinary Research · doi:10.1051/vetres/2009012 · Cited by 14
“In this group of proteins, pUL17 protein orthologs are found in alpha-, beta- and gammaherpesviruses [17, 26, 40].”
BackgroundEBV Vaccines in the Prevention and Treatment of Nasopharyngeal Carcinoma
Zhang, W., Wang, C., Meng, Y., He, L., & Dong, M. (2025) · Vaccines · doi:10.3390/vaccines13050478 · Cited by 16
“Analogous to the architecture of other herpesviruses, EBV is an enveloped virus featuring multiple viral glycoproteins, including gp350, gp42, gH, gL, and gB, which play pivotal roles in receptor recognition, viral adherence, and the fusion of virus–host membranes [53].”
Dai, J., SoRelle, E. D., Heckenberg, E., Song, L., Cable, J. M., Crawford, G. E., & Luftig, M. A. (2023) · mBio · doi:10.1128/mbio.02444-23 · Cited by 12
“CD19 + B cells were isolated from PBMCs using the BD iMag Negative Isolation Kit (BD, 558007) and subsequently infected with the wild-type (WT) B95-8 Epstein-Barr virus strain as previously described (19).”
MethodSelf-citationRole of Virus-Induced EGFR Trafficking in Proviral Functions
Noh, S. S., & Shin, H. J. (2023) · Biomolecules · doi:10.3390/biom13121766 · Cited by 20
“EBV is an enveloped double-stranded DNA virus (dsDNA) [68], while EBV latent membrane protein 1 (LMP1) is an oncoprotein related to EBV-induced cell transformation that activates several signaling pathways, such as the phosphatidylinositol 3-kinase (PI3K)/Akt and NF-κ B signaling pathways [69–72].”
BackgroundEBV-positive glycoproteins associated with nasopharyngeal carcinoma
Zeng, C., Qiao, M., Chen, Y., & Xie, H. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155427 · Cited by 9
Walter, R. M., Majumder, K., & Kalejta, R. F. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012516 · Cited by 10
Utilising proteomic approaches to understand oncogenic human herpesviruses (Review)
Owen, C. B., Hughes, D. J., Baquero-Pérez, B., Berndt, A., Schumann, S., Jackson, B. R., & Whitehouse, A. (2014) · Molecular and Clinical Oncology · doi:10.3892/mco.2014.341 · Cited by 11
“Surprisingly, despite being the first true human oncovirus to be discovered, only a single study has used proteomic analyses to comprehensively study EBV virion composition (82).”
Gillen, J., & Zhu, F. (2021) · Viruses · doi:10.3390/v13091828 · Cited by 9
The Epstein–Barr Virus Lytic Life Cycle
Swaminathan, S., & Kenney, S. C. (2008) · Springer eBooks · doi:10.1007/978-0-387-68945-6_13 · Cited by 9
ORF23 of murine gammaherpesvirus 68 is non-essential for in vitro and in vivo infection
Ohno, S., Steer, B., Sattler, C., & Adler, H. (2012) · Journal of General Virology · doi:10.1099/vir.0.041129-0 · Cited by 9
Bjørnevik, K., Mahler, J. V., Bilodeau, P., Rød, B. E., Romanow, G., Mikami, T., Anderson, M., Bobrowski‐Khoury, N., Zhu, H., Nguyen, J., et al. (2026) · Science Translational Medicine · doi:10.1126/scitranslmed.adz6566 · Cited by 13
Chen, T., Zou, X., Xu, Z., Wang, Y., Wang, P., Peng, H., Liu, D., Lin, J., Luo, R., Wang, Y., et al. (2018) · Iranian Journal of Biotechnology · doi:10.21859/ijb.1610 · Cited by 8
“Our analysis uncovered that the nucleotide sequence similarity of the EBV BGLF2 of the Akata strain to that of AG876, HKNPC1, GD2, B95-8, and GD1 strains was up to 99.5% to 100%, and the AA sequence similarities were all up to 100% (Table 1), respectively, clearly indicated that GD1 is the most closely related strain…”
BackgroundInfluentialChao, T.-Y., Cheng, Y.-Y., Wang, Z.-Y., Fang, T.-F., Chang, Y.-R., Fuh, C.-S., Su, M.-T., Su, Y.-W., Hsu, P., Su, Y.-C., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.04369-22 · Cited by 8
“However, only Rab1A was identified as a component of the mature EBV virion (1), suggesting its role in tegumentation and final EBV envelopment.”
BackgroundMethodInfluentialORF45, a multifunctional immediate early and tegument protein of KSHV
Liang, Q., & Zhu, F. (2023) · Journal of Medical Virology · doi:10.1002/jmv.28659 · Cited by 8
“Johannsen et al.(45) also identified virion proteins of EBV and found that the probable tegument proteins BLRF2, BRRF2, BDLF2, and BKRF4 were”
BackgroundIdentification of Viruses Using Microfluidic Protein Profiling and Bayesian Classification
Fruetel, J. A., West, J. A., Debusschere, B., Hukari, K. W., Lane, T. W., Najm, H. N., Ortega, J., Renzi, R. F., Shokair, I. R., & VanderNoot, V. A. (2008) · Analytical Chemistry · doi:10.1021/ac801342m · Cited by 9
EBV-positive human sera contain antibodies against the EBV BMRF-2 protein
Xiao, J., Palefsky, J. M., Herrera, R., Sunshine, C., & Tugizov, S. M. (2009) · Virology · doi:10.1016/j.virol.2009.07.025 · Cited by 8
“EBV BMRF-2 is a multi-span trans-membrane protein and is incorporated into the viral envelope (Johannsen et al., 2004; Tugizov et al., 2003; Xiao et al., 2007).”
BackgroundDong, L., Masaki, Y., Takegami, T., Kawanami, T., Itoh, K., Jin, Z., Huang, C.-R., Tong, X., Fukushima, T., Tanaka, M., et al. (2007) · International Immunology · doi:10.1093/intimm/dxl150 · Cited by 8
“VCA is a complex of incompletely defined EBV late gene products associated with virion particles (21, 22) and expressed in the late period of EBV replication (17, 20 ).”
BackgroundYiu, S. P. T., Liao, Y., Yan, J., Weekes, M. P., & Gewurz, B. E. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2400167122 · Cited by 8
Epstein-Barr virus latent membrane protein 1 subverts IMPDH pathways to drive B-cell oncometabolism
Burton, E. M., Maestri, D., White, S., Liang, J., Mitra, B., Asara, J. M., & Gewurz, B. E. (2025) · PLoS Pathogens · doi:10.1371/journal.ppat.1013092 · Cited by 9
“B95-8 EBV stocks were prepared from B95-8 producer cells as previously described [110,111] and stored at −80 °C. Infectious titer of freshly thawed EBV was determined by primary B-cell transformation assay.”
Nishio, M., Saito, M., Yoshimori, M., Kumaki, Y., Ohashi, A., Susaki, E., Yonese, I., Sawada, M., & Arai, A. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1320292 · Cited by 7
Hutt‐Fletcher, L. M. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0859-2_6 · Cited by 8
Bioinformatic Analysis of UL27 Gene of Duck Plague Virus CHv Strain
Jiang, L., Lin, D., Cheng, A., Wang, M., Zhu, D., Chen, X., Cheng, A., Wang, M., Zhu, D., Jia, R., et al. (2010) · International Conference on Bioinformatics and Biomedical Engineering · doi:10.1109/icbbe.2010.5515191 · Cited by 7
“EBV virions that contain high levels of gB are more infectious than those with low levels of gB (4, 9).”
BackgroundFunk, C., Raschbichler, V., Lieber, D., Wetschky, J., Arnold, E. K., Leimser, J., Biggel, M., Friedel, C. C., Ruzsics, Z., & Bailer, S. M. (2018) · Traffic · doi:10.1111/tra.12627 · Cited by 7
Recombinant Epstein-Barr virus glycoprotein 350 as a serological antigen
Berg, L. P., Thomsson, E., Hasi, G., Bäckström, M., & Bergström, T. B. (2020) · Journal of Virological Methods · doi:10.1016/j.jviromet.2020.113927 · Cited by 7
Kong, X., Zhang, X., Bu, G., Xu, H.-Q., Kang, Y., Sun, C., Zhu, Q., Ma, R.-B., Liu, Z., Zeng, Y., et al. (2022) · Journal of Virology · doi:10.1128/jvi.00336-22 · Cited by 7
“To answer the call to generate prophylactic vaccines, intensive research has concentrated on gp350 (6), which is the first identified ligand for EBV infection into B cells (7) and the most abundant glycoprotein on the surface of EBV virions (8).”
BackgroundIwahori, S., Umaña, A. C., Kalejta, R. F., & Murata, T. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102513 · Cited by 9
Regulation of Epstein-Barr Virus Minor Capsid Protein BORF1 by TRIM5α
Lin, L.-T., Lu, Y.-S., Huang, H.-H., Chen, H., Hsu, S., & Chang, L.-K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315340 · Cited by 7
“The structure of the EBV capsid shell comprises a major capsid protein, VCA, two minor capsid proteins, BDLF1 and BORF1, and a small capsid protein, BFRF3 [27,28].”
BackgroundMurine gammaherpesvirus 68 ORF35 is required for efficient lytic replication and latency
Hikita, S.-I., Yanagi, Y., & Ohno, S. (2015) · Journal of General Virology · doi:10.1099/jgv.0.000310 · Cited by 7
“ORF35 homologues have not been detected in virions of MHV-68, KSHV and EBV (Bortz et al., 2003; Johannsen et al., 2004; Vidick et al., 2013; Zhu et al., 2005), although ORF35 of rhesus monkey rhadinovirus was found in the virion (O’Connor & Kedes, 2006).”
BackgroundInfluentialKumar, D., TIWARI, K., & Rajala, M. S. (2017) · Acta Virologica · doi:10.4149/av_2017_01_56 · Cited by 7
“Other than influenza A virus, packaging of cellular proteins was accounted for in other viruses, to specify few: human CMV (Varnum et al., 2004), HIV (Cen et al., 2004, Linde et al., 2013), EBV (Johannsen et al., 2004).”
Cytokine Storm Syndromes Associated with Epstein–Barr Virus
Verbist, K., & Nichols, K. E. (2019) · Springer eBooks · doi:10.1007/978-3-030-22094-5_15 · Cited by 7
Cytokine Storm Syndromes Associated with Epstein–Barr Virus
Verbist, K., & Nichols, K. E. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-59815-9_16 · Cited by 6
Viruses with a Double-Stranded DNA Genome
Modrow, S., Falke, D., Truyen, U., & Schätzl, H. M. (2013) · Springer eBooks · doi:10.1007/978-3-642-20718-1_19 · Cited by 7
Gershburg, S., Murphy, L., Marschall, M., & Gershburg, E. (2010) · Biochemical Journal · doi:10.1042/bj20100558 · Cited by 6
Systems biology from virus to humans
Lee, Y., Kim, Y.-J., Jung, Y., Kim, K., Kwon, Y., Kim, S. I., & Kang, S. (2015) · Journal of Analytical Science & Technology · doi:10.1186/s40543-015-0047-4 · Cited by 7
“In particular, enveloped viruses have the capability to incorporate numerous host proteins, both into the interior of the virus particles as well as into the lipid envelope (Cantin et al. 2005; Bortz et al. 2003; Johannsen et al. 2004; Kattenhorn et al. 2004; Zhu et al. 2005).”
BackgroundZhang, X., Zhang, Y., Liu, W., & Luo, B. (2023) · Reviews in Medical Virology · doi:10.1002/rmv.2447 · Cited by 5
“BGLF2 is a tegument protein expressed in the late stage of the lytic cycle and functions in the final envelopment of EBV by associating with BBLF1.(105,106) Besides, BGLF2 plays an essential role in invading the host antiviral innate immunity and increasing viral infectivity.”
BackgroundDai, Y.-C., Yeh, S. Y., Cheng, Y.-Y., Huang, W., Liou, G., Yang, T.-Y., Chang, C., Fang, T.-F., Chang, C.-W., Su, M.-T., et al. (2024) · Journal of Virology · doi:10.1128/jvi.01899-23 · Cited by 5
“9D) or by tandem hydrophobic chromatography, tandem MS sequencing, and MS scans in a previous study (58), we favor the hypothesis that IQGAP1 regulates the trafficking of virion-containing vesicles along microtubules to the cytoplasmic membrane (as indicated in Fig.”
MethodSidorov, S., Fux, L., Steiner, K., Bounlom, S., Traxel, S., Azzi, T., Berisha, A., Berger, C., Bernasconi, M., Niggli, F. K., et al. (2021) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-021-03057-5 · Cited by 5
Dissecting functional motifs of the human cytomegalovirus tegument protein pUL71
Fischer, D. (2012) · OPen Access Repositorium der Universität Ulm (OPARU) (Ulm University) · doi:10.18725/oparu-2779 · Cited by 5
Liang, Q., Zhu, Q., Fang, X., Wei, J., Xu, Y.-E., Zuo, Y., Bu, G., Xie, C., Shan, S., Sun, C., et al. (2026) · Science China Life Sciences · doi:10.1007/s11427-025-3102-7 · Cited by 4
Five families of diverse DNA viruses comprehensively restructure the nucleus
Rosemarie, Q., & Sugden, B. (2023) · PLoS Biology · doi:10.1371/journal.pbio.3002347 · Cited by 5
Green, T. M., Santos, M. F., Barsky, S. H., Rappa, G., & Lorico, A. (2016) · Current Pathobiology Reports · doi:10.1007/s40139-016-0116-4 · Cited by 4
Proteomic approaches to investigate gammaherpesvirus biology and associated tumorigenesis
Chappell, D. L., White, M. C., & Damania, B. (2020) · Advances in virus research · doi:10.1016/bs.aivir.2020.10.001 · Cited by 6
“The EBV capsid proteins identified were BcLF1, BDLF1, BFRF3, BORF1, and BBRF1; tegument proteins included BPLF1, BGLF2, BOLF1, BVRF1, BBLF1, BGLF1, BSRF1, BGLF4, BNRF1, BLRF2, BRRF2, BDLF2, and BKRF4; and glycoproteins detected in the EBV envelope were gp350, gB, gH, gL, gp42, gp150, gM, gN, and gp78 (Johannsen et al.…”
BackgroundLiang, T., Chen, H., Liu, L., Zheng, Y., Ma, Z., Min, L., Zhang, J., Wu, L., Ma, J., Liu, Z., et al. (2024) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2024.100729 · Cited by 5
Characteristics and functional roles of glycoprotein K of herpesviruses
Zhang, S., Cheng, A., & Wang, M. (2011) · Reviews in Medical Microbiology · doi:10.1097/mrm.0b013e3283494765 · Cited by 5
Rta is an Epstein-Barr virus tegument protein that improves the stability of capsid protein BORF1
Huang, H.-H., Wang, W., Feng, T.-H., & Chang, L.-K. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.01.017 · Cited by 4
Lang, S. M., & Means, R. E. (2010) · Virology · doi:10.1016/j.virol.2009.12.006 · Cited by 4
Zhang, K., & den Hurk, S. V. D. L. (2017) · Virus Research · doi:10.1016/j.virusres.2017.05.023 · Cited by 4
“The high amount of BNRF1 in the infectious virions (Johannsen et al., 2004) is consistent with the important role of breaking cellular repression at the initial stages of infection.”
BackgroundLoftus, M. S., Verville, N., & Kedes, D. H. (2017) · Journal of Virology · doi:10.1128/jvi.00304-17 · Cited by 4
“Of note, the Marcoil algorithm generated a nearly identical coiled-coil probability profile for a wide range of gammaherpesvirus ORF52 orthologs (Table 1), including those of KSHV, EBV, and MHV-68 (Fig.”
BackgroundInfluentialBonglack, E. N., Hill, K. K., Barry, A. P., Bartlett, A., Castellano‐Escuder, P., Hirschey, M. D., & Luftig, M. A. (2025) · PLoS Pathogens · doi:10.1371/journal.ppat.1012685 · Cited by 6
“B95-8 strain of Epstein-Barr virus was produced from the B95-8 Z-HT cell line as previously described [36].”
Self-citationChromatin Control of EBV Infection and Latency
Lieberman, P. M., & Tempera, I. (2025) · Current topics in microbiology and immunology · doi:10.1007/82_2025_318 · Cited by 10
Sehrawat, S., Osterrieder, N., Schmid, D. S., & Rouse, B. T. (2022) · Microbes and Infection · doi:10.1016/j.micinf.2022.105078 · Cited by 7
“[89] Johannsen E, Luftig M, Chase MR, Weicksel S, Cahir-McFarland E, Illanes D, et al.”
Bruce, A. G., Horst, J. A., & Rose, T. M. (2016) · Virology · doi:10.1016/j.virol.2016.04.003 · Cited by 3
“In most viral species, the gB monomeric subunit is proteolytically cleaved into N-and C-terminal fragments linked by disulphide bonds (Britt, 1984; Britt and Vugler, 1989; Johannsen et al., 2004; Pereira et al., 1982; Rasmussen et al., 1985; Spaete et al., 1988).”
Features and Functions of the Conserved Herpesvirus Tegument Protein UL11 and Its Binding Partners
Yang, L., Wang, M., Cheng, A., Yang, Q., Wu, Y., Huang, J., Tian, B., Jia, R., Liu, M., Zhu, D., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.829754 · Cited by 3
“Interestingly, in all herpesviruses, UL11 expression partially overlaps with UL12 expression (Adam et al., 1995; Johannsen et al., 2004).”
BackgroundHao, B., Li, J., Sun, C., & Huang, J. (2022) · Virus Genes · doi:10.1007/s11262-022-01961-1 · Cited by 3
“Cytoskeleton Actin, cytoplasmic A4 ACT4 gi|7441427 AcMNPV [18], AIHV [91], EBV [92], HIV [65, 93], HSV [52], HCMV [94], KSHV [95, 96],MMLV [97], MPV [98], RSV [99], VV [98]”
BackgroundInfluentialNaz, A., Yousaf, H., Zaman, N., Rauff, B., Obaid, A., & Awan, F. M. (2025) · Gene Reports · doi:10.1016/j.genrep.2025.102137 · Cited by 3
Larrat, S., Morand, P., Bas, A., Vigne, S., Crance, J., Boyer, V., Nicod, S., Grossi, L., Buisson, M., Burmeister, W. P., et al. (2008) · Antiviral Therapy · doi:10.1177/135965350901400508 · Cited by 3
“The EBV PR, present in mature virions, could elicit a specific T-cell-mediated immune response in vivo [21,30].”
Robinson, T. J., Forte, E., Salinas, R., Puri, S., Marengo, M. S., García-Blanco, M. A., & Luftig, M. A. (2012) · RNA · doi:10.1261/rna.033621.112 · Cited by 3
Self-citationGeris, J. M., Duval, L. M., & Balfour, H. H. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818731-9.00074-4 · Cited by 3
Omics-Level Approaches to Studying Gammaherpesvirus Infection
Hisam, F., Konakalla, A. R., Berisha, E., Castro, M. D. C. C., Mukherjee, S., Wang, C., Sheirbon, B. R., Delgado, T., & Sanchez, E. L. (2026) · Pathogens · doi:10.3390/pathogens15070713 · Cited by 3
“Proteomic analysis of GHVs has identified structural and regulatory viral proteins, elucidating their roles in viral replication, immune evasion, and disease pathogenesis [31,180].”
InfluentialLópez, R., Urquiza, M., Patiño, L. H., Suárez, J., Reyes, C., Patarroyo, M. A., & Patarroyo, M. E. (2005) · Biochimie · doi:10.1016/j.biochi.2005.04.009 · Cited by 2
“p140 is extracted with NP-40 plus deoxycholate, while large tegument protein is not, suggesting that p140 is membrane associated [15].”
BackgroundFingeroth, J. D. (2016) · ASM Press eBooks · doi:10.1128/9781555819439.ch25 · Cited by 2
Preparation of monoclonal antibodies against Epstein-Barr virus glycoprotein 350
Zheng, J., Zeng, X., Zeng, L., Ye, X., Zhong, Z., Wu, Y., Qiu, Y., & Liu, R. (2023) · Virus Genes · doi:10.1007/s11262-023-02013-y · Cited by 2
Functional Analysis and Characterization of Epstein Barr Virus Latent Membrane Protein 2b
Tomaszewski-Flick, M. J. (2008) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 2
Ikebuchi, R., Isaac, A. W., Yoshii, K., Doulabi, E. M., Löf, L., Azimi, A., Chen, L., Fredolini, C., Gallini, R., Landegren, U. D., et al. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.02.143 · Cited by 2
Characterization of Kaposi's Sarcoma- Associated Herpesvirus Open Reading Frames 58 and 27
Quiceno, J. L. (2010) · Seton Hall University eRepository (Seton Hall University) · Cited by 2
Single-cell characterization of transcriptomic heterogeneity in lymphoblastoid cell linesPreprint
SoRelle, E. D., Dai, J., Zhou, J. Y., Giamberardino, S. N., Bailey, J. A., Gregory, S. G., Chan, C. C. W., & Luftig, M. A. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.24.311886 · Cited by 2
Self-citationEpstein-Barr virus promotes survival through germinal center light zone chromatin architecturePreprint
Dai, J., Heckenberg, E., Song, L., Crawford, G. E., & Luftig, M. A. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.22.350108 · Cited by 3
“CD19+ B cells were isolated from PBMCs using the BD iMag Negative Isolation Kit (BD, 558007) and subsequently infected with the wildtype (WT) B95-8 Epstein-Barr virus strain as previously described (Johannsen et al., 2004).”
MethodSelf-citationSoRelle, E. D., Dai, J., Reinoso-Vizcaíno, N. M., Barry, A. P., Chan, C. C. W., & Luftig, M. A. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.02.23.481342 · Cited by 2
Self-citationDesign, Structure, and Immunogenicity of a Soluble Prefusion-stabilized EBV gB AntigenPreprint
McCool, R. S., Acreman, C. M., Powell, A. E., Picucci, S. I., Stieh, D. J., Huynh, J., Caruso, H., Park, S., O’Rear, J., Chen, J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.19.654955 · Cited by 2
Research progress on the vaccine of Epstein-Barr virus
Jiang, Z., XianShu, T. I. A. N., Chu, X. I. E., Zhong, Q., Cong, S. U. N., & Zeng, M. (2024) · Scientia Sinica Vitae · doi:10.1360/ssv-2024-0179 · Cited by 1
The use of peptides for deciphering the mechanism of EBV, HPV, and HCV invasion of human cells
Perdomo-Joven, D., Guzmán, F., & Urquiza, M. (2025) · Exploration of Drug Science · doi:10.37349/eds.2025.1008103 · Cited by 1
Hardy, S. R., Chhan, C. B., Davis, A. R., & McGuire, A. T. (2025) · Current topics in microbiology and immunology · doi:10.1007/82_2025_300 · Cited by 2
Guan, L., Zhang, X., Xu, Z., Li, Y., Zhang, L., Wang, H., Zhang, Z., Wei, X., Liu, Y., Qin, Q., et al. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02585-2 · Cited by 1
“Rab1 GTPase activity is required to produce the viral assembly compartment and for final envelopment of Epstein-Barr virus (EBV), and interestingly, Rab1 has been shown to be a component of the mature EBV virion [48, 49].”
Poudyal, R., Renne, R., & Kladde, M. P. (2017) · Epigenetics and human health · doi:10.1007/978-3-319-55021-3_2 · Cited by 2
Wei, W. L., Ee, C. J., Ying, L. J., & Li, M. (2022) · Springer eBooks · doi:10.1007/978-981-16-9869-9_38 · Cited by 1
A brief overview of the Epstein Barr virus and its association with Burkitt's lymphoma
Farzanehpour, M., Fard, A. M. M., & Ghaleh, H. E. G. (2022) · Romanian Journal of Military Medicine · doi:10.55453/rjmm.2022.125.3.4 · Cited by 1
Breakthrough for Epstein-Barr virus vaccine development: gB nanoparticle vaccine
Sun, C., Xie, C., & Zeng, M. (2023) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2023-1153 · Cited by 1
Current Insights into the Maturation of Epstein–Barr Virus Particles
Nanbo, A. (2024) · Microorganisms · doi:10.3390/microorganisms12040806 · Cited by 1
Fischer, F., Mücke, J., Werny, L., Gerrer, K., Mihatsch, L., Zehetmaier, S., Riedel, I., Geisperger, J., Bodenhausen, M., Schulte-Hillen, L., et al. (2024) · Virology Journal · doi:10.1186/s12985-024-02411-0 · Cited by 3
“EB-VLP contain about half of the more than 80 viral proteins that are encoded on the viral genome [47].”
BackgroundViren mit doppelsträngigem DNA-Genom
Modrow, S., Truyen, U., & Schätzl, H. M. (2021) · Springer eBooks · doi:10.1007/978-3-662-61781-6_19 · Cited by 1
Mechanism of superior B cell immortalisation activity of type 1 Epstein-Barr virus
Tzellos, S. (2014) · Spiral (Imperial College London) · doi:10.25560/23223 · Cited by 1
Modern diagnosis of Epstein-Barr virus infections and post-transplant lymphoproliferative disease
Aalto, S. M. (2007) · Työväentutkimus Vuosikirja · Cited by 1
Virion proteomics of large DNA viruses
Wang, R., Hú, Z., Wáng, H., & Dèng, F. (2009) · Virologica Sinica · doi:10.1007/s12250-009-3062-z · Cited by 2
“(2, 105) and murine cytomegalovirus (MCMV) (45) of the betaherpesviruses and Epstein-Barr virus (EBV) (43), Kaposi’s sarcoma-associated herpesvirus (KSHV)”
Current list of HBD fusion proteins_
Gr, C. (2016) · Cited by 1
Characterization of receptor use and entry mechanisms in two KSHV infection systems
TerBush, A. A. (2018) · eScholarship (California Digital Library) · Cited by 2
赵, 霞., 周, 圣., 黄, 灿., 魏, 于., & 刘, 锐. (2010) · Scientia Sinica Vitae · doi:10.1360/zc2010-40-9-767 · Cited by 1
Yousaf, H., & Naz, A. (2022) · Research Square · doi:10.21203/rs.3.rs-2305929/v1 · Cited by 1
DNA Damage Response Suppresses Epstein-Barr Virus-Driven Proliferation of Primary Human B Cells
Nikitin, P. A. (2012) · DukeSpace (Duke University)
Fox, C. P. (2011) · University of Birmingham Institutional Research Archive (University of Birmingham)
Davies, M. L. (2010) · D-Scholarship@Pitt (University of Pittsburgh)
Metadata
- Authors
- Johannsen, E., Luftig, M., Chase, M. R., Weicksel, S., Cahir-McFarland, E., Illanes, D., Sarracino, D., & Kieff, E.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Kieff, Elliott
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2004-11-08
- Volume
- 101
- Issue
- 46
- Pages
- 16286-16291
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC528973
- OpenAlex
- W2080385928
- Cited by
- 450
- References
- 35
- Citations by year
- 2026: 8 · 2025: 14 · 2024: 31 · 2023: 31 · 2022: 21 · 2021: 15 · 2020: 23 · 2019: 19 · 2018: 25 · 2017: 18 · 2016: 20 · 2015: 26 · 2014: 19 · 2013: 13 · 2012: 19
- FWCI
- 8.82
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Leukemia and Lymphoma Society
- National Institutes of Health (5k08ai049943-02)
- National Cancer Institute (CA47006, CA 85180, R35CA047006, P01CA087661, R01CA047006, R01CA085180, CA87661)
- National Institute of Allergy and Infectious Diseases (1K-08 AI49943-03)
- Topics
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Health Sciences › Medicine › Infectious Diseases › Herpesvirus Infections and Treatments
- Health Sciences › Medicine › Epidemiology › Cytomegalovirus and herpesvirus research
- Keywords
- Epstein-Barr virus, tegument proteins, envelope glycoprotein, lytic replication, actin, cofilin, heat shock proteins, latent infection
- MeSH terms
- Chromatography, Liquid, Clone Cells, Herpesvirus 4, Human, Humans, Lymphocytes, Microscopy, Electron, Phosphorylation, Mass Spectrometry, Viral Envelope Proteins, Viral Proteins, Virus Replication, Open Reading Frames, Capsid Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.